--- title: "Germany's GKV cannabis cut draws DHV… | Cannabivo" description: "Germany’s DHV says a Bundestag-Bundesrat vote cut GKV reimbursement for cannabis flowers and early-stage medical cannabis treatments." canonical: https://cannabivo.com/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement language: en robots: index, follow og_type: article type: research-article language_alternates: en: https://cannabivo.com/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement.md cs: https://cannabivo.com/cs/novinky/politika/nemecke-skrty-v-uhradach-gkv-za-lecebne-konopi-vyvolaly-kritiku-dhv.md de: https://cannabivo.com/de/news/politik/deutschlands-gkv-cannabis-kuerzung-loest-dhv-kritik-wegen-erstattung-aus.md es: https://cannabivo.com/es/noticias/politica/el-recorte-del-gkv-al-cannabis-en-alemania-desata-el-rechazo-del-dhv-por-el-reembolso.md fr: https://cannabivo.com/fr/actualites/politique/en-allemagne-la-reduction-du-remboursement-gkv-du-cannabis-suscite-les-critiques-de-la-dhv.md hu: https://cannabivo.com/hu/hirek/szabalyozas/nemetorszag-gkv-cannabis-teritescsokkentese-dhv-felhaborodast-valt-ki.md it: https://cannabivo.com/it/notizie/politica/il-taglio-del-rimborso-gkv-per-la-cannabis-in-germania-scatena-la-reazione-della-dhv.md nl: https://cannabivo.com/nl/nieuws/beleid/duitse-gkv-cannabisbeperking-lokt-dhv-tegenreactie-uit-over-vergoeding.md pl: https://cannabivo.com/pl/aktualnosci/polityka/ciecia-refundacji-konopi-w-gkv-wywoluja-sprzeciw-dhv.md pt: https://cannabivo.com/pt/noticias/politica/alemanha-restringe-reembolso-da-gkv-para-cannabis-e-provoca-reacao-negativa-da-dhv.md ru: https://cannabivo.com/ru/novosti/politika/sokrashchenie-vozmeshcheniya-gkv-za-kannabis-v-germanii-vyzvalo-kritiku-dhv.md tr: https://cannabivo.com/tr/haberler/politika/almanyanin-gkv-cannabis-geri-odemesini-kismasi-dhvnin-tepkisini-cekti.md zh: https://cannabivo.com/zh/news/zhengce/deguo-gkv-dama-baoxiao-xuejian-yinfa-dhv-fandan.md ja: https://cannabivo.com/ja/news/seisaku/doitsu-no-gkv-kannabisu-shoukan-shukushou-ni-dhv-ga-hanpatsu.md ar: https://cannabivo.com/ar/akhbar/siyasat/khafd-almania-lisidad-gkv-lilqanb-yuthir-radd-dhv.md ko: https://cannabivo.com/ko/news/jeongchaek/dogil-gkv-cannabis-hwangeup-chukso-dhv-banbal.md pt-br: https://cannabivo.com/pt-br/noticias/politica/corte-no-reembolso-da-gkv-para-cannabis-na-alemanha-provoca-reacao-da-dhv.md hi: https://cannabivo.com/hi/samachar/niti/jarmani-ki-gkv-cannabis-pratipoorti-katauti-par-dhv-ka-tikha-virodh.md generated: 2026-07-29 --- > **Machine-readable Markdown rendering.** This is a Markdown representation of a web page, > served for AI agents and crawlers as a token-efficient alternative to the full HTML. > Full interactive HTML version: https://cannabivo.com/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement > Canonical URL: https://cannabivo.com/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement > Available languages: en, cs, de, es, fr, hu, it, nl, pl, pt, ru, tr, zh, ja, ar, ko, pt-br, hi [![German Bundestag committee table with medical-cannabis reimbursement files and health-insurance folders](/images/uploads/5ae24223-540c-4b15-a630-33691f8636ad/news-hero-germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement-1920x1080.jpg)](/images/uploads/5ae24223-540c-4b15-a630-33691f8636ad/news-hero-germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement-1920x1080.avif "View image full size") [Policy](/news/policy "Policy") 8 min read # Germany's GKV cannabis cut draws DHV backlash over reimbursement ![Portrait of Rob Harley, Cannabivo news desk](/images/uploads/5f094d99-3443-4907-8555-2910851fd38a/rob-harley-1920x1920.jpg)By [Rob Harley](/user-profile?u=a65dddce-73db-40b5-8660-fe93612a7384 "View the author's member profile")Published July 14, 2026in [Policy](/news/policy "Policy") Germany’s DHV says a Bundestag-Bundesrat vote cut GKV reimbursement for cannabis flowers and early-stage medical cannabis treatments. ![Portrait of Rob Harley, Cannabivo news desk](/images/uploads/5f094d99-3443-4907-8555-2910851fd38a/rob-harley-1920x1920.jpg)By [Rob Harley](/user-profile?u=a65dddce-73db-40b5-8660-fe93612a7384 "View the author's member profile") Rob Harley has reported on cannabis law and the non-profit association movement across Europe for the past decade. He focuses on how regulation actually reaches the members who use cannabis social clubs — the paperwork, the limits, and the slow build of public trust. His work for Cannabivo aims to be accurate, sourced, and free of hype. [More articles by this author](/news/author/rob-harley "See all articles by this author")Published July 14, 2026in [Policy](/news/policy "Policy") In this article1. [Germany narrows GKV cannabis reimbursement](/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement#germany-narrows-gkv-cannabis-reimbursement "Germany narrows GKV cannabis reimbursement") 2. [The committee route behind the final text](/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement#the-committee-route-behind-the-final-text "The committee route behind the final text") 3. [What insured patients lose at the prescription stage](/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement#what-insured-patients-lose-at-the-prescription-stage "What insured patients lose at the prescription stage") 4. [Exilby's launch price sits at the centre of the dispute](/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement#exilby-s-launch-price-sits-at-the-centre-of-the-dispute "Exilby's launch price sits at the centre of the dispute") 5. [The remaining questions for patients and insurers](/news/policy/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement#the-remaining-questions-for-patients-and-insurers "The remaining questions for patients and insurers") [Germany](/germany "709 Cannabis Social Clubs in Germany (2026)")’s statutory health insurance cannabis rules were sharply narrowed on 10 July 2026, and the German Cannabis Association (DHV) called the move scandalous. In a [DHV press release](https://hanfverband.de/hanfverband-skandaloese-entscheidung-zu-gkv-cannabis "DHV press release"), the group said Germany’s Bundestag and Bundesrat cut GKV reimbursement for medical cannabis flowers, blocked reimbursement for compounded cannabis medicines during the first six months of treatment, and left insured patients with only two THC finished medicines to start therapy. ## Germany narrows GKV cannabis reimbursement For readers outside Germany, **GKV** is the country’s statutory health insurance system, and this vote changes what it will pay for when medical cannabis is prescribed. The DHV says Germany’s Bundestag and Bundesrat have sharply narrowed reimbursement: **cannabis flowers** lose coverage, and a late tightening excludes **compounded medicines** from reimbursement in the first six months of treatment. [![Bundestag committee table with medical-cannabis reimbursement files and microphones](/images/uploads/3c385bff-789e-4735-b4bf-9dae3720f0c6/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement-german-bundestag-committe-1920x1080.jpg)](/images/uploads/3c385bff-789e-4735-b4bf-9dae3720f0c6/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement-german-bundestag-committe-1920x1080.avif "View image full size") A Bundestag committee table reflects the reimbursement vote that narrowed cannabis coverage.The DHV’s before-and-after picture is easier to read in table form: What the GKV vote changed for statutory patients | Area | Before the vote | After the vote | Source | |---|---|---|---| | Cannabis flowers | Some flower therapy could be reimbursed for eligible statutory patients. | That reimbursement path is removed. | [DHV press release](https://hanfverband.de/hanfverband-skandaloese-entscheidung-zu-gkv-cannabis "DHV press release") | | Compounded cannabis medicines | Compounded medicines could still be reimbursed under the normal treatment pathway. | No reimbursement in the first six months of treatment. | [DHV news roundup](https://hanfverband.de/endgueltig-gkv-erstattung-eingeschraenkt-dhv-news-515 "DHV news roundup") | | Treatment start options | Patients and doctors had a wider range of flower and extract therapies to work with. | Only Sativex and Exilby remain as THC finished medicines for therapy start. | [DHV press release](https://hanfverband.de/hanfverband-skandaloese-entscheidung-zu-gkv-cannabis "DHV press release") | Three numbers show how tightly the field has been reduced: The scale of the restriction 6 monthsCompounded medicines blocked from reimbursement at treatment start 2THC finished medicines left for therapy start hundredsFlower varieties the DHV says are affected That is why the association frames the decision as more than a technical change. It is a cut in choice at the exact point where patients and prescribers are deciding how to start treatment. ## The committee route behind the final text DHV says the final text was not just the result of a clean administrative process. According to the association, a **CSU** initiative drove the tightening and the recommendation was then carried by votes from **CDU, CSU and SPD** in Germany’s health committee. The timeline the DHV describes looks like this: How the decision moved from hearing to final vote 1. 22 June 2026G-BA hearing Prof. Hecken, then chair of Germany’s Federal Joint Committee (G-BA), argued for a six-month period with no reimbursement for compounded medicines and named Exilby as a possible alternative. 2. 30 June 2026Hecken leaves the G-BA chair Hecken stepped down on his own request, so he no longer has to defend the recommendation. 3. 10 July 2026Bundestag and Bundesrat approve the restriction Germany’s federal chambers adopted the tighter reimbursement rule for medical cannabis patients insured under GKV. The hearing matters because it showed the direction of travel before the vote. On **22 June 2026**, Hecken argued for a six-month period in which compounded medicines would not be reimbursed and explicitly named **Exilby**, the newly approved product from Munich company Vertanical, as a possible alternative. DHV also says Vertanical founder and shareholder Clemens Fischer had donated **€200,000** to the CSU, **€100,000** to the SPD and **€90,000** to the CDU before the last federal election. > This is something I have never seen in 24 years as DHV chair. > > Georg Wurth The donations DHV cites are broken down like this: Donations cited by DHV (EUR) Taken together, the association’s complaint is that the policy signal and the product signal point in the same direction: away from plant-based reimbursement, and toward a single named finished medicine with an unsettled price. ## What insured patients lose at the prescription stage For insured patients, the practical effect is blunt. DHV says many people who already had reimbursement for **cannabis flowers** will not find an adequate replacement in the remaining options, and the new setup does not include an inhaled route for pain spikes. The association’s main patient concerns are: - Reimbursement for medical cannabis flowers is removed. - All compounded cannabis medicines are excluded from reimbursement in the first six months of treatment. - The only THC finished medicines left for therapy start are Sativex and Exilby. - DHV says neither of those options offers an inhaled route for pain spikes. Why the first six months matter The new rule bites hardest at treatment start: compounded medicines are excluded from reimbursement during the opening six months, while the remaining THC finished medicines do not offer an inhaled option for pain spikes. At the pharmacy counter, the change will be visible in paperwork and reimbursement decisions rather than headlines: [![German pharmacy counter with prescription forms and a health insurance card](/images/uploads/d40a91cf-3d14-4b61-8d14-a6a300df64b7/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement-german-pharmacy-counter-w-1920x1080.jpg)](/images/uploads/d40a91cf-3d14-4b61-8d14-a6a300df64b7/germany-s-gkv-cannabis-cut-draws-dhv-backlash-over-reimbursement-german-pharmacy-counter-w-1920x1080.avif "View image full size") The reimbursement change will be felt first at the pharmacy counter and in claim paperwork.That is the point DHV keeps returning to: this is a restriction in the day-to-day mechanics of treatment, not just a symbolic vote in Berlin. ## Exilby's launch price sits at the centre of the dispute The pricing debate is why the decision around **Exilby** matters beyond one product name. As we explained in our earlier explainer on how Germany sets the price of a cannabis finished medicinal product, the opening months of a launch are controlled by the company, not by a negotiated insurer price. ### A company-controlled window before insurer talks DHV says Exilby has no negotiated price with the health insurers yet. For the first six months, Vertanical alone sets the price; only after that does the company negotiate an reimbursement amount with Germany’s **GKV-Spitzenverband**. That is why the actual cost to statutory insurers is still open. On the DHV’s reading, that produces three problems: 1. Moving from flowers to finished medicines does not obviously save money. 2. The statutory funds cannot yet see the final reimbursement price for Exilby. 3. A savings-driven rule looks hard to square with recommending a product whose insurer price is still unknown. The association’s bottom line is simple: a narrower menu for patients, and no clear evidence that Germany’s statutory system will spend less. ## The remaining questions for patients and insurers Readers will likely come back to the same three questions: who can still start treatment, what is covered at the start, and how much this new framework will cost once the price settles. Questions readers are asking about the GKV cannabis change What exactly changed for Germany’s GKV cannabis patients?Germany’s Bundestag and Bundesrat cut reimbursement for medical cannabis flowers and barred reimbursement for compounded cannabis medicines during the first six months of treatment. Which THC finished medicines remain available at treatment start?According to DHV, only Sativex and Exilby remain as THC finished medicines for insured patients starting therapy. Why is DHV calling the decision scandalous?DHV says many flower patients will not have an adequate replacement, there is no inhaled option for pain spikes among the remaining medicines, and the new rule is unlikely to save money if the system shifts toward more expensive finished products. What does DHV say about the political process?The association says a CSU initiative drove the tightening, the committee recommendation passed with CDU, CSU and SPD votes, and it points to donations from Vertanical founder Clemens Fischer to those parties. Main takeaways - Germany’s Bundestag and Bundesrat tightened GKV reimbursement for medical cannabis, removing coverage for flowers and blocking compounded medicines at treatment start. - DHV says only Sativex and Exilby now remain as THC finished medicines for therapy start, and neither gives patients an inhaled option for pain spikes. - The association argues the decision is unlikely to save money and may instead push insured patients toward a narrower, more expensive treatment path. - DHV also questions the political process, citing the committee route, the G-BA hearing on 22 June, and donations it says Vertanical founder Clemens Fischer made to CDU, CSU and SPD. For DHV, Germany’s latest GKV move is not a fine-tuning exercise but a hard narrowing of treatment choice for insured patients. The real test now is whether the promised savings ever appear, or whether the system simply ends up paying more for fewer options. ## Sources 1. [Endgültig! GKV-Erstattung eingeschränkt | DHV-News # 515 (hanfverband.de)](https://hanfverband.de/endgueltig-gkv-erstattung-eingeschraenkt-dhv-news-515 "Open source in a new tab: https://hanfverband.de/endgueltig-gkv-erstattung-eingeschraenkt-dhv-news-515") 2. [Hanfverband: Skandalöse Entscheidung zu GKV & Cannabis (hanfverband.de)](https://hanfverband.de/hanfverband-skandaloese-entscheidung-zu-gkv-cannabis "Open source in a new tab: https://hanfverband.de/hanfverband-skandaloese-entscheidung-zu-gkv-cannabis") 3. [Ascend Wellness Joins Uplisting Wave With DEA Registration and Stock Split Plans (businessofcannabis.com)](https://businessofcannabis.com/ascend-wellness-joins-uplisting-wave-with-dea-registration-and-stock-split-plans/ "Open source in a new tab: https://businessofcannabis.com/ascend-wellness-joins-uplisting-wave-with-dea-registration-and-stock-split-plans/") 4. [US Rescheduling Hearing Nears End as Opposition’s Own Witness Acknowledges Cannabis Fits Schedule III Standard (businessofcannabis.com)](https://businessofcannabis.com/us-rescheduling-hearing-nears-end-as-oppositions-own-witness-acknowledges-cannabis-fits-schedule-iii-standard/ "Open source in a new tab: https://businessofcannabis.com/us-rescheduling-hearing-nears-end-as-oppositions-own-witness-acknowledges-cannabis-fits-schedule-iii-standard/") 5. [A Tale of Two Prohibitions (norml.org)](https://norml.org/blog/2026/07/13/a-tale-of-two-prohibitions/ "Open source in a new tab: https://norml.org/blog/2026/07/13/a-tale-of-two-prohibitions/") 6. [A Significant Step Forward for Georgia’s Medical Cannabis Program (norml.org)](https://norml.org/blog/2026/07/08/a-significant-step-forward-for-georgias-medical-cannabis-program/ "Open source in a new tab: https://norml.org/blog/2026/07/08/a-significant-step-forward-for-georgias-medical-cannabis-program/") 7. [California’s Top Marijuana Regulator Says Local Bans ‘Benefit’ Illicit Market, With 97% Of Busts In Counties Without Legal Growers (marijuanamoment.net)](https://www.marijuanamoment.net/californias-top-marijuana-regulator-says-local-bans-benefit-illicit-market-with-97-of-busts-in-counties-without-legal-growers/ "Open source in a new tab: https://www.marijuanamoment.net/californias-top-marijuana-regulator-says-local-bans-benefit-illicit-market-with-97-of-busts-in-counties-without-legal-growers/") 8. [Idaho Medical Marijuana Initiative Fails To Qualify For November Ballot After Campaign Falls Short In Signature Drive (marijuanamoment.net)](https://www.marijuanamoment.net/idaho-medical-marijuana-initiative-fails-to-qualify-for-november-ballot-after-campaign-falls-short-in-signature-drive/ "Open source in a new tab: https://www.marijuanamoment.net/idaho-medical-marijuana-initiative-fails-to-qualify-for-november-ballot-after-campaign-falls-short-in-signature-drive/") 9. [From Sacred to Illegal: Inside India’s Cannabis Debate (talkingdrugs.org)](https://www.talkingdrugs.org/from-sacred-to-illegal-inside-indias-cannabis-debate/ "Open source in a new tab: https://www.talkingdrugs.org/from-sacred-to-illegal-inside-indias-cannabis-debate/") 10. [‘Not in the Room’: Nigeria’s New Harm Reduction Masterplan Excludes Reformers (talkingdrugs.org)](https://www.talkingdrugs.org/not-in-the-room-nigerias-new-harm-reduction-masterplan-excludes-reformers/ "Open source in a new tab: https://www.talkingdrugs.org/not-in-the-room-nigerias-new-harm-reduction-masterplan-excludes-reformers/")